Phillips, D. C., Jin, S., Gregory, G. P., Zhang, Q., Xue, J., Zhao, X., . . . Souers, A. J. (2020). A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies. Leukemia, 34(6), 1646. https://doi.org/10.1038/s41375-019-0652-0
Chicago-referens (17:e uppl.)Phillips, Darren C., et al. "A Novel CDK9 Inhibitor Increases the Efficacy of Venetoclax (ABT-199) in Multiple Models of Hematologic Malignancies." Leukemia 34, no. 6 (2020): 1646. https://doi.org/10.1038/s41375-019-0652-0.
MLA-referens (9:e uppl.)Phillips, Darren C., et al. "A Novel CDK9 Inhibitor Increases the Efficacy of Venetoclax (ABT-199) in Multiple Models of Hematologic Malignancies." Leukemia, vol. 34, no. 6, 2020, p. 1646, https://doi.org/10.1038/s41375-019-0652-0.
